Rothera Mark

Avg. Two Year Performance

277% Avg. Purchase Return
94% Compound
81% Avg. Sale Return
34% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return9%31%24%44%277%
Purchase Success Rate1 of 11 of 11 of 11 of 11 of 1
Average Sale Return9%6%21%69%81%
Sale Success Rate3 of 31 of 32 of 33 of 33 of 3
Drugs » Biotechnology

President and CEO, Director:

Holdings: 100.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Major

Global President:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Chief Commercial Officer:

Holdings: 42.95K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

See Remarks, Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--